Ningning Cheng

985 total citations
30 papers, 838 citations indexed

About

Ningning Cheng is a scholar working on Epidemiology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ningning Cheng has authored 30 papers receiving a total of 838 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 8 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ningning Cheng's work include Lung Cancer Treatments and Mutations (7 papers), Cancer-related molecular mechanisms research (5 papers) and Respiratory viral infections research (4 papers). Ningning Cheng is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Cancer-related molecular mechanisms research (5 papers) and Respiratory viral infections research (4 papers). Ningning Cheng collaborates with scholars based in China and United States. Ningning Cheng's co-authors include Xuefei Li, Shengxiang Ren, Chao Zhao, Weijing Cai, Yishi Zhang, Mingchuan Zhao, Caicun Zhou, Hui Pan, Qi Wang and Xiaoxia Chen and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Ningning Cheng

29 papers receiving 831 citations

Peers

Countries citing papers authored by Ningning Cheng

Since Specialization

Citations

This map shows the geographic impact of Ningning Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ningning Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ningning Cheng more than expected).

Fields of papers citing papers by Ningning Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ningning Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ningning Cheng. The network helps show where Ningning Cheng may publish in the future.

Co-authorship network of co-authors of Ningning Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Ningning Cheng. A scholar is included among the top collaborators of Ningning Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ningning Cheng. Ningning Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The CD163/TWEAK/Fn14 axis: A potential therapeutic target for alleviating inflammatory bone loss 2024 ·Journal of Orthopaedic Translation ·(unknown), Yuan Ma, Xuan Huang, Xiaoran Li, Ya-Fei Xu, Ziying Liu, Yuantong Gu, (unknown), (unknown), Yutian Wang, Ningning Cheng, (unknown), (unknown), (unknown), Guanqiao Liu, (unknown), Songyun Deng, Nan Jiang, (unknown), Bin Yu	2
2	Anesthesia management of patients undergoing off-pump coronary artery bypass grafting: A retrospective study of single center 2023 ·Frontiers in Surgery ·(unknown), Tong Sun, Ningning Cheng, Jingjing Liu, (unknown), Lihong Wang, (unknown), Mei‐Fang Chen, (unknown), Yun-tai Yao, (unknown)	1
3	The protective immunity induced by intranasally inoculated serotype 63 chimpanzee adenovirus vector expressing human respiratory syncytial virus prefusion fusion glycoprotein in BALB/c mice 2022 ·Frontiers in Microbiology ·Lei Huang, Meiqing Liu, (unknown), Ningning Cheng, (unknown), Yan-Peng Zheng, Xiang-Lei Peng, Jie‐mei Yu, Yuan-Hui Fu, Jinsheng He	2
4	The mechanism and pharmacodynamics of 2-((1H-indol-3-yl)thio/sulfinyl)-N-pheny acetamide derivative as a novel inhibitor against human respiratory syncytial virus 2022 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Ningning Cheng, Nan Jiang, Yuan-Hui Fu, (unknown), Xiang-Lei Peng, Jie‐mei Yu, Shan Cen, Yucheng Wang, Guoning Zhang, Yan-Peng Zheng, Jinsheng He	1
5	Synthesis and antiviral activity of a series of novel quinoline derivatives as anti-RSV or anti-IAV agents 2021 ·European Journal of Medicinal Chemistry ·Minghua Wang, Guoning Zhang, Jianyuan Zhao, Ningning Cheng, Yujia Wang, Yuan-Hui Fu, Yan-Peng Zheng, Juxian Wang, (unknown), Shan Cen, Jinsheng He, (unknown)	38
6	HOTAIR induces EGFR-TKIs resistance in non-small cell lung cancer through epithelial-mesenchymal transition 2020 ·Lung Cancer ·Qi Wang, Xuefei Li, Shengxiang Ren, Chunxia Su, Chunyu Li, Wěi Li, Jia Yu, Ningning Cheng, Caicun Zhou	34
7	Optimization and characterisation of commercial water-based volatile corrosion inhibitor 2019 ·International Journal of Corrosion and Scale Inhibition ·Ningning Cheng, Benjamín Valdez, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
8	Phase I Trial of Intensity-Modulated Hyperfractionated Radiotherapy Boost with Concurrent Chemotherapy Immediately Following Standard Chemoradiotherapy in Patients Primarily with Advanced Intra-thoracic/Cervical Esophageal Squamous Cell Carcinomas 2019 ·International Journal of Radiation OncologyBiologyPhysics ·Ningning Cheng, Yong Liu, (unknown), Yi Xu, Tiening Zhang, Ying Chen, (unknown), Ye Hu, Shengyu Yao, Zijie Wang, Chungang Wang, Zhixiao Chen, Zhekai Hu, (unknown), Tingfeng Chen	2
9	Seroprevalance of antibodies specific for severe fever with thrombocytopenia syndrome virus and the discovery of asymptomatic infections in Henan Province, China 2019 ·PLoS neglected tropical diseases ·Yanhua Du, Ningning Cheng, Yi Li, Haifeng Wang, Ai-Guo You, Jia Su, (unknown), Hongxia Ma, Bianli Xu, Xueyong Huang	16
10	Histone deacetylation, as opposed to promoter methylation, results in epigenetic BIM silencing and resistance to EGFR TKI in NSCLC 2017 ·Oncology Letters ·Mingchuan Zhao, Yishi Zhang, Jiayu Li, Xuefei Li, Ningning Cheng, Qi Wang, Weijing Cai, Chao Zhao, Yayi He, Jianhua Chang, Caicun Zhou	11
11	De Novo Characterization of Fall Dormant and Nondormant Alfalfa (Medicago sativa L.) Leaf Transcriptome and Identification of Candidate Genes Related to Fall Dormancy 2015 ·PLoS ONE ·(unknown), Yinghua Shi, Ningning Cheng, (unknown), Wenna Fan, Chengzhang Wang	40
12	Serum Levels of the Cancer-Testis Antigen POTEE and Its Clinical Significance in Non-Small-Cell Lung Cancer 2015 ·PLoS ONE ·Qi Wang, Xuefei Li, Shengxiang Ren, Ningning Cheng, Mingchuan Zhao, Yishi Zhang, Jiayu Li, Weijing Cai, Chao Zhao, (unknown), Caicun Zhou	16
13	Serum levels of the cancer-testis antigen POTEE and its clinical significance in non-small cell lung cancer. 2015 ·Journal of Clinical Oncology ·Qi Wang, Xuefei Li, Shengxiang Ren, Ningning Cheng, Weijing Cai, Chao Zhao, Mingchuan Zhao, Jiayu Li, Caicun Zhou	2
14	High expression of E-cadherin in pleural effusion cells predicts better prognosis in lung adenocarcinoma patients. 2015 ·PubMed ·Chao Zhao, Xuefei Li, Chunxia Su, Jiayu Li, Ningning Cheng, Shengxiang Ren, Xiaoxia Chen, Caicun Zhou	11
15	Peripheral Blood for Epidermal Growth Factor Receptor Mutation Detection in Non-Small Cell Lung Cancer Patients 2014 ·Translational Oncology ·Xuefei Li, (unknown), Shengxiang Ren, Xiaoxia Chen, Weijing Cai, Fei Zhou, Yishi Zhang, Chunxia Su, Chao Zhao, Jiayu Li, Ningning Cheng, Mingchuan Zhao, Caicun Zhou	64
16	The Bim deletion polymorphism clinical profile and its relation with tyrosine kinase inhibitor resistance in Chinese patients with non–small cell lung cancer 2014 ·Cancer ·Mingchuan Zhao, Yishi Zhang, Weijing Cai, Jiayu Li, Fei Zhou, Ningning Cheng, (unknown), Chao Zhao, Xuefei Li, Shengxiang Ren, Caicun Zhou, Fred R. Hirsch	77
17	Microarray expression profile of long non-coding RNAs in EGFR-TKIs resistance of human non-small cell lung cancer 2014 ·Oncology Reports ·Ningning Cheng, Xuefei Li, Chao Zhao, Shengxiang Ren, Xiaoxia Chen, Weijing Cai, Mingchuan Zhao, Yishi Zhang, Jiayu Li, Qi Wang, Caicun Zhou	79
18	MiR-200c overexpression is associated with better efficacy of EGFR-TKIs in non-small cell lung cancer patients with EGFR wild-type 2014 ·Oncotarget ·Jiayu Li, Xuefei Li, Shengxiang Ren, Xiaoxia Chen, Yishi Zhang, Fei Zhou, Mingchuan Zhao, Chao Zhao, Xiu Chen, Ningning Cheng, (unknown), (unknown), Fred R. Hirsch	53
19	A Behavior Pattern Based Mobility Simulation Framework for Office Environments 2009 ·(unknown), Ningning Cheng, Guihai Chen	3
20	Priming with a DNA vaccine delivered by attenuated Salmonella typhimurium and boosting with a killed vaccine confers protection of chickens against infection with the H9 subtype of avian influenza virus 2008 ·Vaccine ·Zhiming Pan, Xiaoming Zhang, Shizhong Geng, Ningning Cheng, Lin Sun, (unknown), Jinlin Huang, Xinan Jiao	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact